• AAPL 170.025
  • TSLA 171.6899
  • AMZN 180.51
  • MSFT 409.35
  • INTC 31.545
  • EURUSD 1.0697
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PA /
  3. ABVX.PA

Abivax SA (ABVX PA) stock market data APIs

€15.27 0.45(3%) as of April 26, 2024

Abivax SA Financial Data Overview

15.16
15.27
-
15.1
14.93
7.89-19.7
932 M
62 918 K
4 493 K
-0.589
1.461
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ABVX',
Type: 'Common Stock',
Name: 'Abivax SA',
Exchange: 'PA',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'France',
CountryISO: 'FR',
OpenFigi: NULL,
ISIN: 'FR0012333284',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

Abivax SA Fundamental Data is available in our Financial Data APIs

  • Net Revenue 4 493 K
  • EBITDA -127 251 000
  • Earnings Per Share -3.43
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Abivax SA Earnings via APIs

  • Latest Release 2023-11-29
  • EPS/Forecast -0.589

Get Abivax SA End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Abivax SA latest news via APIs

Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors

PARIS, FRANCE / ACCESSWIRE / July 11, 2023 / Abivax SA (Euronext Paris: FR0012333284 - ABVX), a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune...

Abivax receives "Capital Market Transaction of the Year Award" at the European Mediscience Awards 2023

The award recognizes a significant capital market transaction in the biotech sector Abivax received the award for its oversubscribed EUR 130M cross-over financing at market price with top-tier US and ...
Do you have any questions?
support@eodhistoricaldata.com